North Carolina Books Over $2B in Drug-Manufacturing Expansions in 2020 | North Carolina Biotechnology Center
Rendering of the ApiJect gigafactory under construction in RTP. -- ApiJect image Life sciences companies from around the state, nation and world are expanding their capacity to manufacture pharmaceuticals and biological therapies in North Carolina. Expansions announced in 2020 will bring more than $2.3 billion in investment and 2,800 new jobs in biopharma manufacturing to the state in coming months and years. Ten companies will first create construction-related jobs and then bioscience jobs as they build and operationalize new or expanded plants in communities including Clayton, Durham, Gree...